AliveCor
We believe some of the most transformative businesses of the next decade will be in health and life sciences. We are particularly interested in investments that reflect the convergence of the physical, digital, virtual, and biological world. Areas of specific focus include longevity, patient-enabled health management, and synthetic biology as it impacts information technology. The intelligent collection and synthesis of data will be a driving force behind advances in those fields.
All Health & Life Sciences
Aqtual
Bionaut Labs
CareSignal
EXIT: M&A
Colossal
Curebase
Deciduous Therapeutics
Deep Longevity
EXIT: IPO (SEHK:0575.HK)
Discure
Docbot
Elevian
eXo
Feno Labs
Form Bio
Fountain Therapeutic Services
Gallant Pet
Gameto
Holoclara
Human in Motion Robotics
Immunis Biomedical
Insilico Medicine
iota Biosciences
EXIT: M&A
Iviva Medical
EXIT: M&A
KeyCare
Matrisome Bio
Meru Health
Omeat
Openwater
OURA Health
EXIT:
Proprio
Seed
SeQureDX
Solarea Bio
Stealth Longevity Company
Stuff That Works
Switch Therapeutics
Symbiome
Syntis Bio
Viome
Technological developments such as AI, Blockchain, Sensors, VR, and 3D printing, are accelerating at exponential rates and revolutionizing human productivity. BOLD believes the convergence of these exponential technologies will enable entrepreneurs to create better, more personalized products and services at increasingly faster speeds and dramatically lower costs. By democratizing access, these BOLD entrepreneurs and their companies will transform every industry while uplifting humanity.
All Deep Tech & Productivity
Akitra
Atomiton
Chef Robotics
Crowdz
DigiLens
Dreamscape Immersive
Dreamscape Learn
Earth Force
Figure AI
GuRu
Hyperloop
EXIT: M&A
Kindred
EXIT: M&A
Liquid AI
MagicCube
Metawave
Mighty Buildings
Mojo Vision
Neutrino8
EXIT: M&A
ParkourSC
ProRata.ai
Pyka
Relativity Space
Rugged Robotics
Singularity
Synadia
Terramera